Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 1/20 | 0.53 |
| ▸ | TOP2A | P11388 | 1/20 | 0.44 |
| ▸ | KIF11 | P52732 | 12/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GPR3 | P46089 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18666144 | 0.94 | AHR (0.49) | AHRTOP2AKIF11ALDH1A1GPR3 | |
| SCHEMBL18553436 | 0.85 | AHR (0.49) | AHRTOP2AKIF11ALDH1A1GPR3 | |
| SCHEMBL18666428 | 0.82 | CDK4 (0.43) | AHRALDH1A1HSD17B10KDM4EMAPT | |
| SCHEMBL19831835 | 0.82 | AHR (0.53) | AHRTOP2AKIF11ALDH1A1GPR3 | |
| SCHEMBL18553445 | 0.82 | CYP1A2 (0.40) | AHRTOP2AALDH1A1HSD17B10KDM4E | |
| SCHEMBL18553629 | 0.81 | AHR (0.55) | AHRTOP2AKIF11ALDH1A1GPR3 | |
| SCHEMBL24341366 | 0.80 | CDK4 (0.43) | AHRKDM4EMAPT | |
| SCHEMBL21128608 | 0.79 | AHR (0.49) | AHRTOP2AKIF11ALDH1A1GPR3 | |
| SCHEMBL17464183 | 0.79 | DYRK1A (0.44) | AHRALDH1A1HSD17B10KDM4EMAPT | |
| SCHEMBL19108670 | 0.78 | AHR (0.50) | AHRALDH1A1HSD17B10KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11299459-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2022-04-12 | — | — | US | disclosed |
| WO-2017030307-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS COMPRISING SAME | 덕산네오룩스 주식회사 | 2017-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11299459-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | PIEZO1, OCIAD1, TMEM109 | AHR 3687/4885TOP2A 3743/4885KIF11 2133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.